PRUNE2 and malignant tumor of parathyroid gland: As CDC73 mutations may underlie both benign and malignant parathyroid tumors with varying penetrance and phenotypes, one can, therefore, speculate that mutations of the PRUNE2 gene could also give rise to similarly varying parathyroid tumor phenotypes with similarly varying penetrance [6,53,54].